Back

Optum Health Education

  • Inflammatory Bowel Diseases
  • Janus Kinase Inhibitors

Personalized Medicine in Inflammatory Bowel Disease Management

Explore the role of personalized medicine in the management of inflammatory bowel disease (IBD), including the genetic and environmental factors that contribute to this disease. The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) framework of evidence- and consensus-based recommendations for IBD treatment strategies will be reviewed, and the significance of biomarkers in guiding individualized therapy will be highlighted, with a focus on emerging therapies such as JAK inhibitors and S1P receptor modulators.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 creditsDietetic CPEUsUp to 0.75 creditsNursingUp to 0.75 creditsPharmacyUp to 0.75 creditsPsychologyUp to 0.75 creditsSocial WorkUp to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.75 credits
  • Released
    Jul 25, 2025
  • Last day to claim credit
    Jul 26, 2028 2 years left